Imaging the Front of the Eye at Cell Level With a New Device
Tests a new eye imaging device in adults with glaucoma linked to other eye disorders.
Plain-language title generated from the registry record
Registry title: oCular Examination at Cell RESolution With Optical TransmissionTomography
Key facts
- Where
- Paris, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06976034, who can take part
Where in France
- Centre Hospitalier National D'ophtalmologie Des Quinze VingtsParis, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- Trial code
- NCT06976034
- Record updated
- 16 May 2025
- Original description
Understanding the pathogenesis of eye diseases has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems, such as optical coherence tomography (OCT), are limited in terms of resolution, acquisition speed or access to certain eye functions. Our team has participated in the development of a new generation of imaging technology known as optical transmission tomography (OTT), which enables imaging of the anterior parts of the eye with high cellular resolution, a wide field of view and reduced examination delay.Read full original descriptionShow less
oCular Examination at Cell RESolution With Optical TransmissionTomography
Understanding the pathogenesis of eye diseases has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems, such as optical coherence tomography (OCT), are limited in terms of resolution, acquisition speed or access to certain eye functions. Our team has participated in the development of a new generation of imaging technology known as optical transmission tomography (OTT), which enables imaging of the anterior parts of the eye with high cellular resolution, a wide field of view and reduced examination delay.
Inclusion: For Patients:; 200 subjects aged 18 to 80 years; Male or female; with an ocular disease affecting the cornea, ocular surface, lens (cataract) or glaucoma, or requiring refractive surgery or post-refractive surgery follow-up; Are covered by the French Assurance Maladie; Have signed an express, free and informed consent form; For Healthy volunteers:; 100 subjects aged 18 to 80 years; Male or female; Healthy subjects with no known pathology directly or indirectly affecting ocular structures; Covered by the French Assurance Maladie; Having signed an express, free and informed consent form.
Exclusion: Conjunctivitis or other contagious contact disease in active phase; For all participants:; Inability to hold a still position on a standard ophthalmic chin rest; Having an implanted pacemaker or other electronic medical device; Having a predisposition to iridocorneal angle closure; Vulnerable persons or persons under legal protection (pregnant or breast-feeding women; persons under guardianship,.